F015 Follicular Rescue in Scarring Alopecias: Treating to Halt Disease Progression and Grow Hair
DESCRIPTION
This course will help the dermatologist understand the indications for treating scarring alopecias. The faculty will discuss therapeutic approaches and emerging literature on lichen planopilaris, frontal fibrosing alopecia, and central centrifugal cicatricial alopecia. Dermatoscopic and pathologic cues to viable hair growth in the scarring scalp will be covered. Familiar clinical treatments used in new combinations as well as an approach to healthy hair care practices will be covered. Utilization of new therapies, like PRP and microneedling as well as indications for adding treatments like oral minoxidil for adjunct treatment, will also be discussed.
LEARNING OBJECTIVES
Describe the concept of follicular rescue in scarring forms of hair loss
Demonstrate the signs of treatable scarring alopecias using dermoscopic and pathologic cues
Discuss the therapeutic ladder of treatments to treat scarring alopecias with familiar and new therapies
SCHEDULE
1:00 PM
Introduction
Crystal Aguh, MD, FAAD
1:05 PM
Metabolic Influences on Scalp Fibrosis
Lindsey Bordone, MD, FAAD
1:25 PM
Updates on our Understanding of CCCA
Crystal Aguh, MD, FAAD
1:45 PM
FFA and LPP overview and emerging therapies
Jamie B. MacKelfresh, MD, FAAD
2:05 PM
Approach to other Scarring Alopecias: DLE, Dissecting Cellulitis, and Folliculitis Decalvans
Loren Krueger, MD, FAAD
2:25 PM
Cosmetic and Procedural interventions for scarring alopecia
Ronda S. Farah, MD, FAAD
2:45 PM
Q&A
DIRECTOR
Crystal Aguh, MD, FAAD
SPEAKERS
Lindsey Bordone, MD, FAAD
Ronda S. Farah, MD, FAAD
Loren Krueger, MD, FAAD
Jamie B. MacKelfresh, MD, FAAD
DISCLOSURES
Crystal Aguh, MD, FAAD
CP Skin Health – Advisory Board(Honoraria); Eli Lilly and Company – Consultant(Fees); janssen – Other(Residency/Fellowship Program Funding); Myovant Sciences – Advisory Board(Fees); Olaplex – Advisory Board(Fees); Pfizer Inc. – Consultant(Fees); Procter & Gamble Company – Consultant (1099 relationship)(Fees); UpToDate, Inc – Other(Fees);
Lindsey Bordone, MD, FAAD
No financial relationships exist with ineligible companies.
Ronda S. Farah, MD, FAAD
American Academy of Dermatology – Other(Grants/Research Funding); Arcutis, Inc. – Investigator(Grants/Research Funding); ASLAN Pharmaceuticals – Investigator(Grants/Research Funding); Concert Pharmaceuticals – Investigator(Grants/Research Funding); Early Sullivan Wright Gizer & McRae LLP – Consultant (1099 relationship)(Fees); Eli Lilly – Investigator(Grants/Research Funding); Lumenis Be Ltd. – Consultant (1099 relationship)(Fees); Novartis – Advisory Board(Fees); Pfizer – Investigator(Grants/Research Funding); Pfizer Inc. – Stockholder(No Compensation Received), Stockholder Public Company(No Compensation Received); Technoderma Medicines – Investigator(Grants/Research Funding);
Loren Krueger, MD, FAAD
No financial relationships exist with ineligible companies.
Jamie B. MacKelfresh, MD, FAAD
UpToDate, Inc – Other(Other Financial Benefit);